Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study
Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study
复制标题
单独使用全反式视黄酸 (ATRA) 进行缓解诱导治疗的初始白细胞计数较低的急性早幼粒细胞白血病 (APL) 的长期结果：日本成人白血病研究组 (JALSG) APL97 研究
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Takaaki Ono
中科院分区：
文献类型：
--
作者：
Maeda H;Sogawa K;Sakaguchi K;Abe S;Sagizaka W;Mochizuki S;Horie W;Watanabe T;Shibata Y;Satoh M;Sanda A;Nomura F;Suzuki J.;Takaaki Ono
